When should low‑dose aspirin be initiated after detecting an elevated uterine‑artery pulsatility index in a first‑trimester ultrasound?

When to Start Aspirin After Detecting Elevated Uterine Artery Pulsatility Index

Start low-dose aspirin immediately upon detection of elevated uterine artery pulsatility index during first-trimester screening (11-14 weeks), ideally before 16 weeks of gestation, and continue daily until delivery. 1

Optimal Timing for Initiation

The evidence strongly supports starting aspirin as soon as an elevated uterine artery PI is identified during first-trimester screening:

• Begin aspirin between 12-16 weeks of gestation for maximum effectiveness in preventing preeclampsia, with the critical window being before 16 weeks when defective placentation and inadequate spiral artery remodeling occur. 1

• The American College of Obstetricians and Gynecologists recommends initiation between 12-16 weeks, ideally before 16 weeks, as this timing allows aspirin to improve uteroplacental blood flow during the critical period of placentation. 1

• Do not delay initiation once elevated uterine artery PI is detected—the U.S. Preventive Services Task Force found that initiating aspirin before 16 weeks is more effective than later initiation. 1

Recommended Dosing

The dosing should be higher than the traditional 81 mg used in U.S. practice:

• Prescribe 100-150 mg daily rather than the standard 81 mg dose, as meta-analyses demonstrate that doses ≥100 mg initiated before 16 weeks are significantly more effective (RR 0.33,95% CI 0.19-0.57) for preventing preeclampsia. 1

• The International Society for the Study of Hypertension in Pregnancy recommends 150 mg daily started before 16 weeks for women at increased risk, including those with elevated uterine artery PI. 1

• European guidelines and the International Federation of Gynecology and Obstetrics specifically recommend 150 mg daily for high-risk women identified through first-trimester screening. 1

Mechanistic Rationale

Understanding why early initiation matters helps guide clinical decision-making:

• Defective placentation occurs in the first trimester, and aspirin initiated early can improve spiral artery remodeling during this critical window of placentation. 1

• Aspirin reduces thromboxane A₂ production, decreasing vasoconstriction and platelet aggregation, which supports uteroplacental blood flow during early placentation. 1

• Research demonstrates that early aspirin treatment leads to a greater decrease in uterine artery PI between first and second trimesters in high-risk women, suggesting improved placental perfusion. 2

Duration of Therapy

• Continue aspirin daily until delivery—do not stop at 36 weeks, as this removes protection during the period of highest preeclampsia risk and is not evidence-based. 1

• The American College of Obstetricians and Gynecologists explicitly advises against stopping aspirin at 36 weeks "just to be safe," as preeclampsia risk persists throughout pregnancy and even into the early postpartum period. 1

Safety Profile

Reassure patients about the safety of early aspirin initiation:

• Low-dose aspirin does not increase risks of placental abruption, postpartum hemorrhage, fetal intracranial bleeding, perinatal mortality, or congenital anomalies when started in the first trimester. 1, 3

• Recent analysis of the ASPIRIN trial (11,879 women) found no significant differences in maternal, fetal, or neonatal adverse events when aspirin was initiated before 11 weeks versus later, providing reassuring evidence of early pregnancy safety. 3

Common Pitfalls to Avoid

• Do not wait for additional risk factors to accumulate before starting aspirin—elevated uterine artery PI alone at 11-14 weeks is sufficient indication for prophylaxis. 1

• Do not use 81 mg dosing in women with elevated uterine artery PI—this dose may be suboptimal, and evidence supports 100-150 mg daily for high-risk populations. 1

• Do not discontinue aspirin prematurely—continue until delivery unless there is a specific contraindication such as planned neuraxial anesthesia (in which case stop 7-10 days before scheduled cesarean). 4

Clinical Algorithm

1. At 11-14 week screening: Measure uterine artery pulsatility index
2. If elevated PI detected: Prescribe aspirin 100-150 mg daily immediately (ideally before 16 weeks)
3. Continue daily: Until delivery (do not stop at 36 weeks)
4. For planned cesarean with neuraxial anesthesia: Stop aspirin 7-10 days before scheduled procedure 4